ACTSI Patent Citation

The following language must be included in the text of patent applications resulting from direct or indirect Atlanta Clinical & Translational Science Institute (ACTSI) support:

"This invention was made with government support under NIH Grant No. UL1TR000454 awarded by the National Institutes of Health of the United States government. The government has certain rights in this invention."

Contact Andrew West, ACTSI senior center administrator, with any questions.

Upcoming Events

View All Events

Upcoming Events

View All Events

Discovery News

Discovery

Phlebotomy Training 101: Introduction to Venipuncture

The ACTSI-Clinical Research Network (CRN) and Emory Medical Laboratory announce a new course for Emory University and Healthcare employees. The two-day course will be held on August 18 and 25. Thereafter, students will be assigned to clinical...

Discovery

ACTSI-supports first-in-man clinical trial for Hunter syndrome at Emory University Hospital

A 31-year old man recently received the first investigational enzyme replacement therapy (ERT), Armagen’s AGT-182 (licensed by Shire) for the treatment of neurological complications in patients with Hunter syndrome. The trial is...

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?